Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020488
Filing Date
2018-08-08
Accepted
2018-08-08 16:16:53
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vsar-10q_20180630.htm 10-Q 1308509
2 EX-31.1 vsar-ex311_6.htm EX-31.1 16937
3 EX-32.1 vsar-ex321_7.htm EX-32.1 4187
  Complete submission text file 0001564590-18-020488.txt   3821464

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vsar-20180630.xml EX-101.INS 708025
5 XBRL TAXONOMY EXTENSION SCHEMA vsar-20180630.xsd EX-101.SCH 30747
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20180630_cal.xml EX-101.CAL 30533
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20180630_def.xml EX-101.DEF 59441
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20180630_lab.xml EX-101.LAB 204305
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20180630_pre.xml EX-101.PRE 149664
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 181001566
SIC: 2834 Pharmaceutical Preparations